[{"Assets_0_FY_USD":8008859000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":457897000.0,"NetIncomeLossConverted_4_FY_USD":1758675000.0,"NetIncomeLossConverted_1_FY_USD":553500000.0,"StockholdersEquity_0_FY_USD":5755057000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":30184000.0,"EarningsPerShareBasic_1_FY_USD":18.5,"EarningsPerShareBasic_4_FY_USD":58.93,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29843000.0,"RevenuesConverted_1_FY_USD":624500000.0,"EarningsPerShareDiluted_1_FY_USD":18.31,"EarningsPerShareDiluted_4_FY_USD":58.27,"RevenuesConverted_4_FY_USD":2311700000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20200302"}]